Drug Developer PPD Targets $1.53B For Public Debut

By Elise Hansen · January 27, 2020, 4:18 PM EST

Private equity-backed drug developer PPD Inc. said Monday it's targeting roughly $1.53 billion at midpoint for its upcoming initial public offering, which is steered by Simpson Thacher and sees Latham &...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login